[1] Michelakis ED. Pulmonary arterial hypertension:yesterday, today, tomorrow[J]. Circ Res, 2014, 115(1):109-114. [2] Hoeper MM, Mayer E, Simonneau G, et al. Chronic throm-boembolic pulmonary hypertension[J]. Circulation, 2006, 113(16):2011-2020. [3] Courboulin A, Paulin R, Giguere NJ, et al. Role for miR-204 in human pulmonary arterial hypertension[J]. J Exp Med, 2011, 208(3):535-548. [4] Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension[J]. J Clin Invest, 2012, 122(12):4306-4313. [5] 钱国清, 王良兴, 陈婵, 等. 大鼠细小肺动脉平滑肌细胞原代培养和鉴定方法的研究[J]. 中国应用生理学杂志, 2010, 26(1):125-128. [6] 虞晓明, 郭瑞, 唐江锋, 等. 小鼠肺细小动脉平滑肌细胞原代培养和鉴定以及低氧对其增殖与凋亡的影响[J]. 中国病理生理杂志, 2014, 30(9):1724-1728. [7] Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease[J]. Physiol Rev, 2004, 84(3):767-801. [8] Owens GK. Regulation of differentiation of vascular smooth muscle cells[J]. Physiol Rev, 1995, 75(3):487-517. [9] Savai R, Al-Tamari HM, Sedding D, et al. Pro-proliferative and inflammatory signaling converge on FoxO1 transcription fa ctor in pulmonary hypertension[J]. Nat Med, 2014, 20(11):1289-1300. [10] Roque M, Kim WJ, Gazdoin M, et al. CCR2 deficiency de-creases intimal hyperplasia after arterial injury[J]. Arte-rioscler Thromb Vasc Biol, 2002, 22(4):554-559. [11] Li P, Zhu N, Yi B, et al. MicroRNA-663 Regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation[J]. Circ Res, 2013, 113(10):1117-1127. [12] 孟立平, 周昌钻, 郭艳, 等. 黄酒中抑制同型半胱氨酸诱导的大鼠血管平滑肌细胞增殖和迁移成分探讨[J]. 中国应用生理学杂志, 2015, 31(5):437-442. [13] Tallquist M, Kazlauskas A. PDGF signaling in cells and mice[J]. Cytokine Growth Factor Rev, 2004, 15(4):205-213. |